Booth Andrew — SEC insider filings

SEC reporting owner CIK 1834411. 17 insider filings on record with FilingPulse; latest filed 2026-11-16.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2021-06-09 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
AbCellera Biologics Inc. (ABCL)Chief Financial Officer177 legs · 255,400 sh · $2,211,6391 leg · 1,200,000 sh · $30,600,00019

Insider filings — Booth Andrew

FiledFormIssuerReported transactionsSource
2026-11-164AbCellera Biologics Inc. (ABCL)Option exercise (M): 50,000 @ $0.32 · Gift (G): 50,000 @ $0 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2026-11-134AbCellera Biologics Inc. (ABCL)Purchase (P): 8,600 @ $11.33EDGAR
2026-08-144AbCellera Biologics Inc. (ABCL)Purchase (P): 37,200 @ $10.32EDGAR
2026-06-034AbCellera Biologics Inc. (ABCL)Option exercise (M): 250,000 @ $0.19 · Option exercise (M): 250,000 (derivative) @ $0EDGAR
2026-02-274AbCellera Biologics Inc. (ABCL)Purchase (P): 42,600 @ $3.42EDGAR
2026-01-054AbCellera Biologics Inc. (ABCL)Grant/award (A): 808,898 (derivative) @ $0EDGAR
2025-01-034AbCellera Biologics Inc. (ABCL)Grant/award (A): 1,352,054 (derivative) @ $0EDGAR
2024-01-164AbCellera Biologics Inc. (ABCL)Grant/award (A): 770,416 (derivative) @ $0EDGAR
2023-05-264AbCellera Biologics Inc. (ABCL)Purchase (P): 14,500 @ $6.85EDGAR
2022-12-224AbCellera Biologics Inc. (ABCL)Option exercise (M): 50,000 @ $0.19 · Gift (G): 50,000 @ $0 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2022-12-054AbCellera Biologics Inc. (ABCL)Grant/award (A): 485,661 (derivative) @ $0EDGAR
2022-05-164AbCellera Biologics Inc. (ABCL)Purchase (P): 85,000 @ $5.79EDGAR
2021-12-104AbCellera Biologics Inc. (ABCL)Option exercise (M): 500,000 @ $0.32 · Option exercise (M): 500,000 (derivative) @ $0EDGAR
2021-12-094AbCellera Biologics Inc. (ABCL)Grant/award (A): 406,020 (derivative) @ $0EDGAR
2021-11-154AbCellera Biologics Inc. (ABCL)Purchase (P): 53,500 @ $14.74 · Purchase (P): 14,000 @ $14.61EDGAR
2021-06-104AbCellera Biologics Inc. (ABCL)Sale (S): 1,200,000 @ $25.50EDGAR
2021-06-094AbCellera Biologics Inc. (ABCL)Option exercise (M): 600,000 @ $0.19 · Option exercise (M): 600,000 @ $0.32 · Option exercise (M): 600,000 (derivative) @ $0 · Option exercise (M): 600,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1834411 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs